FDA Recalls NaturalCare bioAllers Nasal Spray Due to Manufacturing Defects
Nutraceutical Corporation recalls NaturalCare bioAllers Allergy Nasal Spray nationwide due to manufacturing quality deviations in raw materials. The recalled lots show discoloration and do not meet FDA Good Manufacturing Practice standards.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This FDA Class II recall involves manufacturing quality deviations without reported illnesses or injuries. The specific hazard—discoloration of raw materials—is not a known pathogen or allergen. The recall appears to be a precautionary manufacturing quality issue.
Plain-English summary
Nutraceutical Corporation is recalling NaturalCare bioAllers Allergy Nasal Spray nationwide. The recall affects 13,974 units distributed throughout the USA due to Good Manufacturing Practice (CGMP) deviations. The raw material supplier had recalled the material due to discoloration.
The affected lots include: 221263 (expires 10/24), 222047 and 222048 (expire 02/25), and 222099 and 222100 (expire 03/25). Consumers should check their products to determine if they have a recalled lot.
Consumers who have purchased this product should not use it. Contact the manufacturer or the place of purchase for instructions on return or disposal.
The recalled product
- Product
- NaturalCare bioAllers, Allergy Nasal Spray, Homeopathic, All Region Formula, 0.8 fl oz( 24mL), Mfd. Nutraceutical Corp., NaturalCare Park City, UT, 84098 USA, UPC 3 71400 70801 9
- Manufacturer
- Nutraceutical Corporation
- Category
- Drug — Allergy Medication
- Hazard
- manufacturing-defect
- discoloration
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (7)
- Lot: 221263
- Exp: 10/24
- 222047
- 222048 Exp: 02/25
- 222099
- 222100
- Exp: 03/25
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27